Anxiogenic-Like Behavioral Phenotype of Mice Deficient in Phosphodiesterase 4B (PDE4B)
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“Inhibition of PDE4 also increases adult neurogenesis (Nakagawa et al, 2002), which is believed to be involved in antidepressant activity (Dranovsky and Hen, 2006; Malberg and Duman, 2003; Santarelli et al, 2003).”
BackgroundChronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Malberg, J. E., & Duman, R. S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300234 · Cited by 815 · cited 2×
“Inhibition of PDE4 also increases adult neurogenesis (Nakagawa et al, 2002), which is believed to be involved in antidepressant activity (Dranovsky and Hen, 2006; Malberg and Duman, 2003; Santarelli et al, 2003).”
BackgroundDISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling
Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S., et al. (2005) · Science · doi:10.1126/science.1112915 · Cited by 648 · cited 2×
“In addition, PDE4B also is involved in schizophrenia by interacting with the DISC1 gene, a candidate susceptibility factor for schizophrenia (Clapcote et al, 2007; Millar et al, 2005).”
BackgroundResultFluoxetine targets early progenitor cells in the adult brain
Encinas, J. M., Vaahtokari, A., & Enikolopov, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601992103 · Cited by 637
Behavioral phenotypes of Disc1 missense mutations in mice
Clapcote, S. J., Lipina, T. V., Millar, J. K., Mackie, S., Christie, S., Ogawa, F., Lerch, J. P., Trimble, K., Uchiyama, M., Sakuraba, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.04.015 · Cited by 526
The functional neuroanatomy of mood disorders
Soares, J. C., & Mann, J. J. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00016-2 · Cited by 379 · cited 1×
“The amygdala and hypothalamus are key regions in the mediation of anxiety and stress responses (Charney and Deutch, 1996), while the frontal cortex and olfactory bulb contribute in the mediation of antidepressant effects on behavior (Soares and Mann, 1997; Webster et al, 2000).”
BackgroundNociception in cyclooxygenase isozyme-deficient mice
Ballou, L. R., Botting, R. M., Goorha, S., Zhang, J., & Vane, J. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180319297 · Cited by 205
Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats
Semba, J., Mataki, C., Yamada, S., Nankai, M., & Toru, M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00477-0 · Cited by 140
Cited by
Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
Lakics, V., Karran, E. H., & Boess, F. G. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.004 · Cited by 463
Meier, S. M., Trontti, K., Purves, K. L., Als, T. D., Grove, J., Laine, M., Pedersen, M. G., Bybjerg-Grauholm, J., Bækved-Hansen, M., Sokolowska, E., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.1119 · Cited by 240
Li, Y.-F., Huang, Y., Amsdell, S. L., Xiao, L., O'Donnell, J. M., & Zhang, H.-T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.66 · Cited by 185
“Antidepressant-like effect of rolipram Previous studies have shown that rolipram (0.5 mg/kg for 8 d) produces antidepressant-like behavior in the FST and TST in a mixed background (C57 × 129) of mice and NIH Swiss mice (Zhang et al. 2002, 2008).”
BackgroundMethodSelf-citationMeier, S. M., & Deckert, J. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1002-7 · Cited by 182
Erlangsen, A., Appadurai, V., Wang, Y., Turecki, G., Mors, O., Werge, T., Mortensen, P. B., Starnawska, A., Børglum, A. D., Schork, A., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0218-y · Cited by 157
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis
Kolb, M., Crestani, B., & Maher, T. M. (2023) · European Respiratory Review · doi:10.1183/16000617.0206-2022 · Cited by 85
Wang, H., Zhang, F.-F., Xu, Y., Fu, H.-R., Wang, X.-D., Wang, L., Chen, W., Xu, X.-Y., Gao, Y.-F., Zhang, J.-G., et al. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa048 · Cited by 84
Rossi, S., De Chiara, V., Musella, A., Sacchetti, L., Cantarella, C., Castelli, M., Cavasinni, F., Motta, C., Studer, V., Bernardi, G., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064196 · Cited by 82
Roflumilast: A potential drug for the treatment of cognitive impairment?
Sugin, L. J. S., Murugesan, A., Bindu, M., & Sunil, K. N. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135281 · Cited by 24
Yang, M., Ding, Q., Zhang, M., Moon, C., & Wang, H. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100237 · Cited by 12
“, 2015); PDE-4B reduction causes anxiogenic and despair-like behavior (Zhang et al., 2008).”
Background
Metadata
- Authors
- Zhang, H.-T., Huang, Y., Masood, A., Stolinski, L. R., Li, Y., Zhang, L., Dlaboga, D., Jin, S.-L. C., Conti, M., & O'Donnell, J. M.
- Venue
- Neuropsychopharmacology
- Published
- 2007-08-15
- Volume
- 33
- Issue
- 7
- Pages
- 1611-1623
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2138529679
- Cited by
- 179
- References
- 11
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.